Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2013-06-04 14:37:13
Reporting Period:
Filing Date:
Accepted Time:
2013-06-04 14:37:13
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1145460 Alere Inc. ALR In Vitro & In Vivo Diagnostic Substances (2835) 043565120
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1466092 Lester Michael Cotton 3200 Windy Hill Road
Suite B-100
Atlanta GA 30339
Global Pres, Health Mgmt No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2013-05-31 8,750 $25.43 8,750 No 4 M Direct
Common Stock Disposition 2013-05-31 8,750 $25.86 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Buy) Disposition 2013-05-31 8,750 $0.00 8,750 $25.43
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2013-02-28 2022-02-28 No 4 M Direct
  1. Represents same day exercise and sale of stock options.
  2. This derivative security does not have a price.
  3. The price represents the average purchase price for 23 separate transactions reported on this line. The price of the transactions reported on this line range from $25.85 to $25.88. The reporting person hereby undertakes to provide upon request to the SEC, the issuer or any stockholder of the issuer the full information regarding the number of shares and prices at which the transaction was effected.